Aldeyra Therapeutics ALDX
NASDAQ ALDX
$1.17 -0.12 (-9.30%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aldeyra Therapeutics (ALDX) Return on Capital Employed [ROCE] (2014 - 2026)

Updated

Aldeyra Therapeutics (ALDX) posted Return on Capital Employed [ROCE] of -50.82% for Q2 2026, up 38.71 percentage points from -89.53% a year earlier and up 12.33 percentage points from the prior quarter.

Analysis

Aldeyra Therapeutics (ALDX) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends

For FY2025, Aldeyra Therapeutics' Return on Capital Employed [ROCE] came in at -58.27%, down 2.53 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -3.93 percentage points (FY2020 to FY2025).
  • In prior years, Aldeyra Therapeutics' Return on Capital Employed [ROCE] was -55.73% in FY2024 (-25.71 pp), -30.02% in FY2023 (+2.65 pp), -32.67% in FY2022 (+5.71 pp) and -38.38% in FY2021 (+15.96 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q3 2024.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in two of the last eight quarters, with an average year-over-year change of -16.50 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q2 2026, with a gain of 38.71 percentage points; the weakest was Q2 2025, with a drop of 48.94 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -63.15% (Q1 2026), -74.84% (Q4 2025) and -85.40% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Aldeyra Therapeutics 70.58 Mn 70.58 Mn - -50.82%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -50.82%
Mar 31, 2026 -63.15%
Dec 31, 2025 -74.84%
Sep 30, 2025 -85.40%
Jun 30, 2025 -89.53%
Mar 31, 2025 -72.27%
Dec 31, 2024 -65.09%
Sep 30, 2024 -47.49%
Jun 30, 2024 -40.58%
Mar 31, 2024 -28.74%
Dec 31, 2023 -34.09%
Sep 30, 2023 -38.81%
Jun 30, 2023 -38.02%
Mar 31, 2023 -39.69%
Dec 31, 2022 -36.84%
Sep 30, 2022 -37.62%
Jun 30, 2022 -33.25%
Mar 31, 2022 -29.25%
Dec 31, 2021 -24.61%
Sep 30, 2021 -21.72%
API Access

Aldeyra Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ALDX&period=max&api_key=YOUR_API_KEY